Javier Szwarcberg

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Paul W. Noble, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2011 · 2.1K citations

Medicine, Clinical Sciences, Pharmacotherapy +8

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Talmadge E. King, Carlo Albera, Williamson Z. Bradford et al. · The Lancet · 2009 · 531 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important Difference

Roland M. du Bois, Derek Weycker, Carlo Albera et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 458 citations · Full text

Medicine, Rehabilitation Medicine, Exercise Testing +16

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

Paul E. Sax, Edwin DeJesus, Anthony Mills et al. · The Lancet · 2012 · 444 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis

Roland M. du Bois, Derek Weycker, Carlo Albera et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 429 citations · Full text

Business, Biostatistics, Pulmonology +15